The Genetic Roots of POIKTMP

While the symptoms of POIKTMP can be seen or felt, the root cause lies deep within the body’s genetic code. A definitive diagnosis requires a pathogenic or likely pathogenic variant in a specific gene called FAM111B in the appropriate clinical context ^[1][2]. Understanding the genetics of this condition can help you navigate the diagnosis and understand why certain symptoms occur.

The FAM111B Gene

Every person has two copies of the FAM111B gene, one from each parent. This gene provides the instructions for making a protein that acts as a putative protease—a type of molecular “scissor” that is predicted to break down other proteins to help the cell function properly ^[3][4].

In POIKTMP, a pathogenic variant in one copy of the FAM111B gene causes the protein to behave abnormally. A leading research model suggests this may act via a gain-of-function mechanism, meaning the enzyme functions improperly and may interfere with normal cellular maintenance, particularly in the nucleus ^[4][5].

How It Is Inherited

POIKTMP follows an autosomal dominant pattern of inheritance. This means a person only needs one mutated copy of the FAM111B gene to have the condition ^[1].

• De Novo Mutations: Most often, the mutation is “de novo,” meaning it occurred for the first time in the individual and was not inherited from either parent ^[6][7].
• Familial Transmission: In some cases, a parent who has the mutation passes it on to their child. If a parent has the mutation, there is a 50% chance of passing it to each of their children ^[1][2].

Genetic Counseling

Consulting with a genetic counselor is important to discuss parental testing, the small risk of germline mosaicism, recurrence counseling, and reproductive options. Because the condition is so rare and symptoms can be mild in some people, parents are often tested to see if they also carry the mutation ^[8].

The Role of “Domains” in Severity

Not all mutations in the FAM111B gene are the same. Scientists have noticed that where the mutation is located on the gene might offer clues about the disease course.

• The Protease Domain: In a 2022 review of 36 reported patients, mutations located within this specific part of the gene were associated with a higher reported frequency of internal organ involvement, such as pulmonary fibrosis (47% vs. 13%) and liver issues (26% vs. 7%) ^[9].
• The D-Box: Another region called the “D-box” has also been associated with a more severe overall disease pattern when mutations cluster there ^[5].

Important Note: These are statistical associations drawn from very small cohorts. They should not be used to determine a child’s or adult’s exact prognosis or dictate a rigid surveillance schedule ^[5][9].

Reaching a Definitive Diagnosis

Because POIKTMP is so rare, it is a differential diagnosis often considered alongside other conditions that cause similar skin changes, most notably Rothmund-Thomson Syndrome (RTS) ^[10].

• Clinical Suspicion: A doctor may suspect POIKTMP if a person has the “triad” of early skin changes (poikiloderma), thin hair, and muscle weakness or tight tendons ^[1][11].
• Genetic Testing: The only way to confirm the diagnosis is through molecular genetic testing, such as a multigene panel or exome sequencing ^[2][6]. This test looks specifically for pathogenic variants in the FAM111B gene.
• Differentiating from RTS: While RTS also causes poikiloderma, it is often evaluated through RECQL4 gene testing and has different risks, such as a higher risk for bone cancer ^[10][12]. Confirming the FAM111B variant ensures the correct monitoring for specific risks, like lung and liver health ^[10].

Variants of Uncertain Significance: If a test returns a variant of uncertain significance (VUS), it means a change was found, but doctors aren’t yet sure if it causes the disease. A VUS should not be used to diagnose POIKTMP, predict disease, or change surveillance. Relatives should not be tested for a VUS without guidance from a genetics professional and the testing laboratory ^[8].